These are scientific papers which may assist, but do not specifically tie HPV vaccines to adverse events:
- Molecular variants of HPV 16 from 4 continents suggest ancient pandemic spread of the virus and its coevolution with humankind (published in 1992) One has to wonder why humans still exist if this virus is so dangerous. Also notable that this was published prior to the development of HPV vaccines.
- A summary of the post-licensure surveillance initiatives for Gardasil Silgard Behind a paywall, but worth examining.
- Reduction in HPV Prevalence – No Evidence to Support HPV Vaccination Reduces HPV Prevalence
- Review of Gardasil, by Diane M Harper
- Review: Immunigenicity, and Efficacy of HPV vaccines in Low and Middle Income Countries (Note: the vast majority of subjects were only followed up on formally for 7 days post-vaccination – remainder of follow-up was on ’unsolicited’ events. This most likely means it was up to the recipients to report, if they were so inclined. The other problem is the ’placebo’ used in the vast majority of these trials was not an inert solution.)
- Transmission of High-Risk HPV between Parents and Infant: a Prospective Study of HPV in Families in Finland
- Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical cancer among patients in Delta Region, Egypt
- HPV infection and cervical neoplasia: associated risk factors
- Reduction in HPV Prevalence—No Evidence to Support HPV Vaccination reduces HPV Prevalence
- Japan: 21 year study to monitor impact of HPV vaccines on cervical cancer
- Topological conformational changes of HPV DNA bound to an insoluble aluminum salt Lee
- HPV vaccines and cancer prevention, science versus activism Tomljenovic/Shaw et al
- Too Fast or Not Too Fast: The FDA’s Approval of Merck’s HPV Vaccine, Gardasil? Tomljenovic/Shaw
- HPV Vaccines as an option for prevention of cervical cancer: How effective and Safe? Tomljenovic/Shaw/Spinosa
- HPV vaccine policy and evidence-based medicine: Are they at odds? Tomljenovic/Shaw
- The pathogenesis of HPV in the development of cervical cancer: are HPV vaccines a safe and effective management strategy?
- Gardasil Vaccination: Evaluating the Risks versus Benefits Tomljenovic
- Prophylactic HPV Vaccines: Current knowledge of Impact on Gynecological Premalignancies Diane Harper/Karen Williams
- HPV Vaccine: Debate over benefits, marketing and new adverse events (JAMA)